The pharmaceutical industry’s understanding of serialization is maturing as companies slowly begin to recognize the added business value supply chain traceability can provide. Historically, the industry’s focus on serialization has been driven by the need to satisfy evolving regulations. However, progressive companies are finally realizing that the benefits of traceability extend far beyond compliance.
Serialization unlocks an end-to-end supply chain visibility that has the potential to yield significant business gains. Through the smart deployment of fully integrated and validated solutions, forward-thinking organizations are looking at the bigger picture, and using serialization as a catalyst for operational efficiency, enhanced partner engagement, and stronger patient-centered care. It’s a sensible move. With the clock ticking toward the enactment of major new regulations to strengthen the medicines supply chain, the industry has a great opportunity to convert compliance into competitive advantage; but exploiting it is all about selecting a technology partner that can give you the visibility to support your vision.